| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ionis Pharmaceuticals, Inc. (IONS) has 21 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. IONS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 260.3K | $19.75M | - | |
| Dir | 164.0K | $12.45M | -8,000 | |
| VP | 100.3K | $7.61M | - | |
| VP | 83.3K | $6.32M | -60,846 | |
| CFO | 82.7K | $6.27M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 15, 2023 | Klein Joseph III60 | Director | Sell | 2,000 | $50.00 | $100,000.00 | -10.9% | -2.3% | -25.2% | |
| Oct 17, 2023 | Swayze Eric63 | EVP Research | Sale+OE | 52 | $47.95 | $2,493.35 | -41.6% | +5.2% | -19.3% | |
| Oct 12, 2023 | Monia Brett P60 | Chief Executive Officer | Sell | 3,770 | $46.00 | $173,420.00 | -3.1% | +13.3% | -16.6% | |
| Sep 28, 2023 | Bennett C Frank64 | EVP, Chief Scientific Officer | Sell | 4,460 | $46.50 | $207,390.00 | -6.4% | +8.4% | -11.7% | |
| Sep 26, 2023 | Parshall B Lynne74 | Director | Sell | 10,000 | $45.13 | $451,268.00 | -10.8% | +10.8% | -11.4% | |
| Sep 26, 2023 | Klein Joseph III60 | Director | Sell | 2,000 | $45.13 | $90,253.60 | -9.8% | +10.8% | -11.4% | |
| Aug 1, 2023 | Diaz Allene M. | Director | Sell | 657 | $41.05 | $26,969.85 | -4.9% | +6.8% | +20.0% | |
| Jul 18, 2023 | Klein Joseph III60 | Director | Sale+OE | 3,555 | $42.00 | $149,310.00 | -14.9% | +14.4% | +14.0% | |
| Jul 7, 2023 | Monia Brett P60 | Chief Executive Officer | Sell | 18,650 | $42.25 | $787,953.17 | -13.3% | +12.1% | +10.3% | |
| May 24, 2023 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sell | 1,527 | $41.70 | $63,675.90 | -3.6% | -4.7% | -7.9% |